WILL MILLER: Open Payments
NPI 1760883441 · DECATUR, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,277 in 187 payments from 17 companies in 2025. Trend: 2023 $1,318 · 2024 $2,150 · 2025 $11,277
Consulting: $7,273Food & beverage: $3,061Travel & lodging: $728Education: $215
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $5,816 |
| UCB, Inc. | 25 | $1,660 |
| Regeneron Healthcare Solutions, Inc. | 18 | $1,546 |
| ABBVIE INC. | 20 | $358 |
| Janssen Biotech, Inc. | 17 | $316 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 23 | $250 |
| Lilly USA, LLC | 17 | $238 |
| Organon LLC | 12 | $200 |
| Amgen Inc. | 8 | $193 |
| PFIZER INC. | 15 | $188 |
Products named: DUPIXENT, Bimzelx, TREMFYA, SKYRIZI, ILUMYA, OTEZLA, CIBINQO, TALTZ.
Industry payments across IL — which companies pay providers there.
